Pharma - The Round-up – 13 November 2018
News in brief from around the world… MPs have written to US pharma company Vertex to demand information on its negotiations with the NHS, China has announced new vaccine regulations and a US appeals court has affirmed Fresenius’s Diprivan patent loss.
Pharma - The Round-up – 06 November 2018
News in brief from around the world… UK politicians have called for patent reforms to combat antimicrobial resistance, while a court in India has banned online drug sales and Mexico’s Supreme Court has ruled to legalise marijuana for personal use in the past week.
Pharma - The Round-up – 30 October 2018
News in brief from around the world… The past week saw President Trump give final clearance to new regulations aimed at curbing the opioid crisis, as well as announcing plans to lower drug prices.
Pharma - The Round-up – 23 October 2018
News in brief from around the world…The regulations allowing the European Medicines Agency to relocate from London to Amsterdam have passed another approval milestone in the past week. The EU is also seeking feedback on changes to its laws on children’s medicines, while US regulators are planning to shrink package sizes for opioids.
Pharma - The Round-up – 16 October 2018
News in brief from round the world… Novartis and Bayer have launched an appeal against the English High Court’s denial of their Avastin judicial review request, Johnson & Johnson has beaten a talc asbestos suit and AbbVie has been sued by investors. Meanwhile, the US is mulling regulations that would oblige drug companies to include their list prices in TV ads and the UK has cleared the way for the prescription of medical cannabis products.
Pharma - The Round-up – 10 October 2018
News in brief from around the world… The UK’s medicines regulator has launched new hard Brexit consultations in the past week and the EMA is at work on revisions to its transparency rules. In the US, the Obama administration’s Health and Human Services deputy general counsel has returned to private practice and the Supreme Court has declined to hear an appeal on clinical trial liability.